Quoin Pharmaceuticals, Ltd.
QNRX
$-0.08
Change (1 day)
$6.18
Year High
$0.43
Year Low
Categories
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Earnings for Quoin Pharmaceuticals, Ltd. (QNRX)
Earnings in 2023 (TTM): $-8,664,189
According to Quoin Pharmaceuticals, Ltd.'s latest financial reports the company's current earnings (TTM) are $-8,664,189. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Quoin Pharmaceuticals, Ltd.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-8,664,189 | $-8,686,573 |
| 2022 | $-9,381,496 | $-9,277,453 |
| 2021 | $-21,462,588 | $-8,518,668 |
| 2020 | $-2,095,364 | $-1,764,052 |
| 2019 | $-1,560,401 | $-1,560,401 |
| 2018 | $15.32 M | $15.32 M |
| 2017 | $10.17 M | $10.17 M |
| 2016 | $15.32 M | $15.32 M |
| 2015 | $-2,617,764 | $-2,617,764 |